Right now the price per share is 20,65$, In this post we are going to talk about the listed company Kura Oncology Inc, its leaders are Kathleen Ford (Chief Operating Officer), Marc Edward Grasso (Chief Financial & Business Officer), Mollie Leoni (Vice President-Clinical Development), Stephen Dale (Chief Medical Officer), Troy E. Wilson (Chairman, President & Chief Executive Officer), they lead it to work in Biotechnology: Biological Products (No Diagnostic Substances) especially in the North America region.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 20,76$ moving between 20,26$ and 21,25$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
